Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963

K-Number: K893532 · 1989-08-21

ApplicantMedipart Jerry Alexander
Decision Date1989-08-21
Product CodeCBN
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963 is the device name listed in this FDA 510(k) record. The listed applicant is Medipart Jerry Alexander. It received FDA 510(k) clearance on 1989-08-21 under 510(k) number K893532. The device is classified under product code CBN. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963?

RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963 is a medical device that received FDA 510(k) clearance on 1989-08-21. The listed applicant is Medipart Jerry Alexander. The 510(k) number is K893532.

When did RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963 receive FDA 510(k) clearance?

RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963 received FDA 510(k) clearance on 1989-08-21, under 510(k) number K893532.

Who is the listed applicant for RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963?

The FDA 510(k) record lists Medipart Jerry Alexander as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963?

The FDA product code for RESUBMITTED RADIOAEROSOL CONT. SYSTEM MP-963 is CBN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medipart Jerry Alexander as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K896885DISPOSABLE RESPIRTORY KIT (MP-200)K896125MEDIPART DISPOSABLE XENON-133 REBREATHING MP-0133MK896124MEDIPART DISPOSABLE XENON-133 REBREATHING MP-0133K896476DISP. RADIOAEROSOL KIT (MP-400-M) TO FIT SHIELDK896475DISP. RADIOAEROSOL KIT (MP-400) TO FIT LEAD SHIELDK894138MEDIPART DISPOSABLE AEROSOL SYSTEM MP-070-PTD

View all 49 devices →

Related Devices (Code: CBN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K223452Nitronox Scavenger PlusParker Hannifin CorporationK193646Dynamic Gas Scavenging System 2 (DGSS - 2)Anesthetic Gas Reclamation, Inc.K160950MINISCAVSedation Systems, LLCK123176ISO-GARD CLEARAIR MASKTeleflexmedical, Inc.K110930ACTIVE WASTE GAS SCAVENGERG. Dundas Co.,Inc.K092031VAPOR-CLEAR, MODEL 100Axon Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑